Novak and coworkers demonstrated that adenoviral vectors expressing RYBP inhibited proliferation of tumour cells by inducing apoptosis, either alone or in combination with TNF‐α and etoposide, thus implicating RYBP as a therapeutic target in cancer 42. The gene discussed is RYBP; the disease is cancer.